Non-ionic surfactant based vesicles (niosomes) in drug delivery

The self assembly of non-ionic surfactants into vesicles was first reported in the seventies by researchers in the cosmetic industry. Since then a number of groups world wide have studied non-ionic surfactant vesicles (niosomes) with a view to evaluating their potential as drug carriers. This articl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 1998-10, Vol.172 (1), p.33-70
Hauptverfasser: Uchegbu, Ijeoma F., Vyas, Suresh P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 70
container_issue 1
container_start_page 33
container_title International journal of pharmaceutics
container_volume 172
creator Uchegbu, Ijeoma F.
Vyas, Suresh P.
description The self assembly of non-ionic surfactants into vesicles was first reported in the seventies by researchers in the cosmetic industry. Since then a number of groups world wide have studied non-ionic surfactant vesicles (niosomes) with a view to evaluating their potential as drug carriers. This article presents a summary of the achievements in the field to date. Niosomes may be formed form a diverse array of amphiphiles bearing sugar, polyoxyethylene, polyglycerol, crown ether and amino acid hydrophilic head groups and these amphiphiles typically possess one to two hydrophobic alkyl, perfluoroalkyl or steroidal groups. The self assembly of surfactants into niosomes is governed not only by the nature of the surfactant but by the presence of membrane additives, the nature of the drug encapsulated and the actual method of preparation. Methods of niosome preparation and the number of different morphologies that have been identified are detailed. The influence of formulation factors on niosome stability is also examined as are methods to optimise drug loading. In vivo these systems have been evaluated as immunological adjuvants, anti-cancer/anti-infective drug targeting agents and carriers of anti-inflammatory drugs. Niosomes have also been used in diagnostic imaging. Efforts to achieve transdermal and ophthalmic drug delivery with some formulations are also discussed.
doi_str_mv 10.1016/S0378-5173(98)00169-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17133054</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517398001690</els_id><sourcerecordid>17133054</sourcerecordid><originalsourceid>FETCH-LOGICAL-c485t-dec584b6e008ca680421c3300f4c5e763024b169ab92bb9f5c8fb1e0c56424913</originalsourceid><addsrcrecordid>eNqFkE9LxDAQxYMouK5-BKEHEfdQnTRpmp5EFv-B6EE9h3Q6lUi3XTPdBb-91V306Glg-L33Zp4QxxLOJUhz8QyqsGkuC3VW2hmMqzKFHTGRtlCp0oXZFZNfZF8cML8DgMmkmojLx75LQ98FTHgVG4-D74ak8kx1siYO2BInZ13ouV8Qz5LQJXVcvSU1tWFN8fNQ7DW-ZTrazql4vbl-md-lD0-39_OrhxS1zYe0JsytrgwBWPTGgs4kKgXQaMypMAoyXY13-6rMqqpscrRNJQkwNzrTpVRTcbrxXcb-Y0U8uEVgpLb1HfUrdrKQo12uRzDfgBh75kiNW8aw8PHTSXDfdbmfutx3F6607qcuB6PuZBvgGX3bRN9h4D-xAQXWjNjlBqPx2XWg6BgDdUh1iISDq_vwT9AXG_h9gg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17133054</pqid></control><display><type>article</type><title>Non-ionic surfactant based vesicles (niosomes) in drug delivery</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Uchegbu, Ijeoma F. ; Vyas, Suresh P.</creator><creatorcontrib>Uchegbu, Ijeoma F. ; Vyas, Suresh P.</creatorcontrib><description>The self assembly of non-ionic surfactants into vesicles was first reported in the seventies by researchers in the cosmetic industry. Since then a number of groups world wide have studied non-ionic surfactant vesicles (niosomes) with a view to evaluating their potential as drug carriers. This article presents a summary of the achievements in the field to date. Niosomes may be formed form a diverse array of amphiphiles bearing sugar, polyoxyethylene, polyglycerol, crown ether and amino acid hydrophilic head groups and these amphiphiles typically possess one to two hydrophobic alkyl, perfluoroalkyl or steroidal groups. The self assembly of surfactants into niosomes is governed not only by the nature of the surfactant but by the presence of membrane additives, the nature of the drug encapsulated and the actual method of preparation. Methods of niosome preparation and the number of different morphologies that have been identified are detailed. The influence of formulation factors on niosome stability is also examined as are methods to optimise drug loading. In vivo these systems have been evaluated as immunological adjuvants, anti-cancer/anti-infective drug targeting agents and carriers of anti-inflammatory drugs. Niosomes have also been used in diagnostic imaging. Efforts to achieve transdermal and ophthalmic drug delivery with some formulations are also discussed.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/S0378-5173(98)00169-0</identifier><identifier>CODEN: IJPHDE</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Biological and medical sciences ; Drug delivery ; General pharmacology ; Medical sciences ; Niosomes ; Non-ionic surfactants ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Self-assembly</subject><ispartof>International journal of pharmaceutics, 1998-10, Vol.172 (1), p.33-70</ispartof><rights>1998 Elsevier Science B.V.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c485t-dec584b6e008ca680421c3300f4c5e763024b169ab92bb9f5c8fb1e0c56424913</citedby><cites>FETCH-LOGICAL-c485t-dec584b6e008ca680421c3300f4c5e763024b169ab92bb9f5c8fb1e0c56424913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0378-5173(98)00169-0$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1603086$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Uchegbu, Ijeoma F.</creatorcontrib><creatorcontrib>Vyas, Suresh P.</creatorcontrib><title>Non-ionic surfactant based vesicles (niosomes) in drug delivery</title><title>International journal of pharmaceutics</title><description>The self assembly of non-ionic surfactants into vesicles was first reported in the seventies by researchers in the cosmetic industry. Since then a number of groups world wide have studied non-ionic surfactant vesicles (niosomes) with a view to evaluating their potential as drug carriers. This article presents a summary of the achievements in the field to date. Niosomes may be formed form a diverse array of amphiphiles bearing sugar, polyoxyethylene, polyglycerol, crown ether and amino acid hydrophilic head groups and these amphiphiles typically possess one to two hydrophobic alkyl, perfluoroalkyl or steroidal groups. The self assembly of surfactants into niosomes is governed not only by the nature of the surfactant but by the presence of membrane additives, the nature of the drug encapsulated and the actual method of preparation. Methods of niosome preparation and the number of different morphologies that have been identified are detailed. The influence of formulation factors on niosome stability is also examined as are methods to optimise drug loading. In vivo these systems have been evaluated as immunological adjuvants, anti-cancer/anti-infective drug targeting agents and carriers of anti-inflammatory drugs. Niosomes have also been used in diagnostic imaging. Efforts to achieve transdermal and ophthalmic drug delivery with some formulations are also discussed.</description><subject>Biological and medical sciences</subject><subject>Drug delivery</subject><subject>General pharmacology</subject><subject>Medical sciences</subject><subject>Niosomes</subject><subject>Non-ionic surfactants</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Self-assembly</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkE9LxDAQxYMouK5-BKEHEfdQnTRpmp5EFv-B6EE9h3Q6lUi3XTPdBb-91V306Glg-L33Zp4QxxLOJUhz8QyqsGkuC3VW2hmMqzKFHTGRtlCp0oXZFZNfZF8cML8DgMmkmojLx75LQ98FTHgVG4-D74ak8kx1siYO2BInZ13ouV8Qz5LQJXVcvSU1tWFN8fNQ7DW-ZTrazql4vbl-md-lD0-39_OrhxS1zYe0JsytrgwBWPTGgs4kKgXQaMypMAoyXY13-6rMqqpscrRNJQkwNzrTpVRTcbrxXcb-Y0U8uEVgpLb1HfUrdrKQo12uRzDfgBh75kiNW8aw8PHTSXDfdbmfutx3F6607qcuB6PuZBvgGX3bRN9h4D-xAQXWjNjlBqPx2XWg6BgDdUh1iISDq_vwT9AXG_h9gg</recordid><startdate>19981015</startdate><enddate>19981015</enddate><creator>Uchegbu, Ijeoma F.</creator><creator>Vyas, Suresh P.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>19981015</creationdate><title>Non-ionic surfactant based vesicles (niosomes) in drug delivery</title><author>Uchegbu, Ijeoma F. ; Vyas, Suresh P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c485t-dec584b6e008ca680421c3300f4c5e763024b169ab92bb9f5c8fb1e0c56424913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Biological and medical sciences</topic><topic>Drug delivery</topic><topic>General pharmacology</topic><topic>Medical sciences</topic><topic>Niosomes</topic><topic>Non-ionic surfactants</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Self-assembly</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uchegbu, Ijeoma F.</creatorcontrib><creatorcontrib>Vyas, Suresh P.</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uchegbu, Ijeoma F.</au><au>Vyas, Suresh P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non-ionic surfactant based vesicles (niosomes) in drug delivery</atitle><jtitle>International journal of pharmaceutics</jtitle><date>1998-10-15</date><risdate>1998</risdate><volume>172</volume><issue>1</issue><spage>33</spage><epage>70</epage><pages>33-70</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><coden>IJPHDE</coden><abstract>The self assembly of non-ionic surfactants into vesicles was first reported in the seventies by researchers in the cosmetic industry. Since then a number of groups world wide have studied non-ionic surfactant vesicles (niosomes) with a view to evaluating their potential as drug carriers. This article presents a summary of the achievements in the field to date. Niosomes may be formed form a diverse array of amphiphiles bearing sugar, polyoxyethylene, polyglycerol, crown ether and amino acid hydrophilic head groups and these amphiphiles typically possess one to two hydrophobic alkyl, perfluoroalkyl or steroidal groups. The self assembly of surfactants into niosomes is governed not only by the nature of the surfactant but by the presence of membrane additives, the nature of the drug encapsulated and the actual method of preparation. Methods of niosome preparation and the number of different morphologies that have been identified are detailed. The influence of formulation factors on niosome stability is also examined as are methods to optimise drug loading. In vivo these systems have been evaluated as immunological adjuvants, anti-cancer/anti-infective drug targeting agents and carriers of anti-inflammatory drugs. Niosomes have also been used in diagnostic imaging. Efforts to achieve transdermal and ophthalmic drug delivery with some formulations are also discussed.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><doi>10.1016/S0378-5173(98)00169-0</doi><tpages>38</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 1998-10, Vol.172 (1), p.33-70
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_17133054
source ScienceDirect Journals (5 years ago - present)
subjects Biological and medical sciences
Drug delivery
General pharmacology
Medical sciences
Niosomes
Non-ionic surfactants
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Self-assembly
title Non-ionic surfactant based vesicles (niosomes) in drug delivery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T17%3A20%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non-ionic%20surfactant%20based%20vesicles%20(niosomes)%20in%20drug%20delivery&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Uchegbu,%20Ijeoma%20F.&rft.date=1998-10-15&rft.volume=172&rft.issue=1&rft.spage=33&rft.epage=70&rft.pages=33-70&rft.issn=0378-5173&rft.eissn=1873-3476&rft.coden=IJPHDE&rft_id=info:doi/10.1016/S0378-5173(98)00169-0&rft_dat=%3Cproquest_cross%3E17133054%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17133054&rft_id=info:pmid/&rft_els_id=S0378517398001690&rfr_iscdi=true